Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
brelovitug
product2 mentionslast seen Nov 10, 2026
Investigational fully human monoclonal antibody binding to hepatitis B surface antigen for chronic hepatitis delta virus treatment.
Relationships 2
Relationship
Mirum Pharmaceuticals, Inc.developsbrelovitug
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- filingSEC EDGARNov 10, 2026Mirum Pharmaceuticals, Inc. 8-K: Item 8.01: Other Events
Mirum Pharmaceuticals, Inc. (the "Company") announced that the primary endpoint was met in the Phase 3 AZURE-4 study evaluating brelovitug
- filingSEC EDGARSep 28, 2026Mirum Pharmaceuticals, Inc. 8-K: Item 8.01: Other Events
the Company announced the primary endpoint was met in the Phase 3 portion of the AZURE-1 study evaluating brelovitug